Chemicals & Advanced Materials Global On demand · 24-48h

Global 5-Aminolevulinic Acid Market Strategic Research Report

Global 5-Aminolevulinic Acid Market Strategic Research Repor…
$3,500 USD
Market Research Reports
Strategic Research Report
Global 5-Aminolevulinic Acid Market
$2312025
8.1%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Purity 98%, Purity 95%, Others

By Application: Agriculture, Medicine, Chemicals For Daily Use, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: SBI Pharmaceuticals, Neopharma, Medac, Midas Pharma, Sobeo Biotech, Xinlian Biochemical, NMT Biotech, Natural Field, Fudan-Zhangjiang, Harworld, East Star Biotech

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 113 pages
Market size 2025
$231
Million USD
Forecast CAGR
8.1%
2025-2032
Forecast 2032
$398.5
Projected
Gebieden
5
Asia Pacific · Latin America · MEA · Europe · North America

Overzicht

Scope of the Report

The global 5-Aminolevulinic Acid market size is predicted to grow from US$ 231 million in 2025 to US$ 399 million in 2032; it is expected to grow at a CAGR of 8.1% from 2026 to 2032.

5-Aminolevulinic acid, an endogenous non-proteinogenic amino acid, is the first compound in the porphyrin synthesis pathway, the pathway that leads to heme in mammals, as well as chlorophyll in plants. 5ALA is used in photodynamic detection and surgery of cancer.

The classification of 5-ALA includes Purity 98%, Purity 95% and Others, and the proportion of Purity 98% is 64%. 5-Aminolevulinic Acid is usually in a free state, and its shape is not stable. It is mostly sold in the form of 5-ALA hydrochloride or 5-ALA phosphate in the market.

The product used in the agricultural field is usually 5-ALA hydrochloride, and its price is low. The price of 5-ALA phosphate products is relatively high, and it can be used in food, medicine, nutritional supplements, cosmetics, etc., and its use is more extensive.

5-ALA is widely used in Agriculture, Medicine, Chemicals for Daily Use and Others. The most proportion of 5-ALA is for Medicine, and the proportion is 61%.

Asia-Pacific is the largest consumption region, with a market share 59%.

Key Questions Addressed in this Report

What is the 10-year outlook for the global 5-Aminolevulinic Acid market?

What factors are driving 5-Aminolevulinic Acid market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do 5-Aminolevulinic Acid market opportunities vary by end market size?

How does 5-Aminolevulinic Acid break out by Type, by Application?

This report presents a comprehensive overview of the global 5-Aminolevulinic Acid market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Purity 98%
  • Purity 95%
  • Others

Segment by Chemical Form

  • Hydrochloride
  • Phosphate

Segment by Process

  • Synthetic Method
  • Microbial Fermentation Method

Segment by Application

  • Agriculture
  • Medicine
  • Chemicals For Daily Use
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global 5-Aminolevulinic Acid market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Agriculture, Medicine, Chemicals For Daily Use evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global 5-Aminolevulinic Acid Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 8.1%
Regional growth momentum
Market share by segment
Key metrics
Base value
$231
2025
Forecast
$398.5
2032
CAGR
8.1%
2025–2032
Gebieden
5
global
Key companies
SBI PharmaceuticalsNeopharmaMedacMidas PharmaSobeo BiotechXinlian BiochemicalNMT BiotechNatural Field
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Purity 98%Purity 95%Others
By Application
AgricultureMedicineChemicals For Daily UseOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Purity 98%
  • 3.1.3 Purity 95%
  • 3.1.4 Others
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Agriculture
  • 4.1.3 Medicine
  • 4.1.4 Chemicals For Daily Use
  • 4.1.5 Others
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 SBI Pharmaceuticals
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Neopharma
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Medac
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Midas Pharma
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Sobeo Biotech
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Xinlian Biochemical
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 NMT Biotech
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Natural Field
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Fudan-Zhangjiang
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Harworld
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 East Star Biotech
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global 5-Aminolevulinic Acid market?
The global 5-Aminolevulinic Acid market is estimated at US$ 231 million in 2025 (base year) and is projected to reach US$ 399 million by 2032.
How fast is the 5-Aminolevulinic Acid market expected to grow?
The market is expected to grow at a CAGR of 8.1% from 2026 to 2032, expanding from US$ 231 million in 2025 to US$ 399 million in 2032, roughly 1.7 times its base-year value.
What does the 5-Aminolevulinic Acid market cover?
5-Aminolevulinic acid, an endogenous non-proteinogenic amino acid, is the first compound in the porphyrin synthesis pathway, the pathway that leads to heme in mammals, as well as chlorophyll in plants. 5ALA is used in photodynamic detection and surgery of cancer.
How is the 5-Aminolevulinic Acid market segmented by type?
By type, the market is segmented into Purity 98%, Purity 95% and Others.
What are the key applications of 5-Aminolevulinic Acid?
Key applications covered include Agriculture, Medicine, Chemicals For Daily Use and Others.
Which companies are profiled in the 5-Aminolevulinic Acid market report?
Key players profiled include SBI Pharmaceuticals, Neopharma, Medac, Midas Pharma, Sobeo Biotech, Xinlian Biochemical, NMT Biotech and Natural Field, among 11 companies covered in total.
What geographies does the 5-Aminolevulinic Acid market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for 5-Aminolevulinic Acid?
What factors are driving 5-Aminolevulinic Acid market growth, globally and by region?
Who should buy the 5-Aminolevulinic Acid market report?
The report is intended for manufacturers and solution providers, distributors and end users in Agriculture, Medicine and Chemicals For Daily Use, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the 5-Aminolevulinic Acid market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.